TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10831944

Group type: EXPERIMENTAL
Intervention: Ablation at the anterior side of the isthmus (group A)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Ablation at the posterior side of the isthmus (group P)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Ablation at the posterior side of the isthmus (group P) after failure at A
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Ablation at the anterior side of the isthmus (group A) after failure at P
Number of subjects: 72

Group type: COMPARATOR
Intervention: Ablation at P
Number of subjects: 72
Study: 9332626

Group type: EXPERIMENTAL
Intervention: Experimental intervention
Number of subjects: 6

Group type: COMPARATOR
Intervention: Active placebo intervention
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Night shifts
Number of subjects: 6
Study: 8229533

Group type: EXPERIMENTAL
Intervention: Intralipid (20% Intralipid at < 12 hours after birth, starting at 0.5 gm/kg and increasing to a maximum of 1.5 gm/kg, maintained through day 7)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Intralipid (20% Intralipid at < 12 hours after birth)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Control (no lipid until after day 7)
Number of subjects: 133
Study: 30132999

Group type: EXPERIMENTAL
Intervention: Neurorehabilitation therapy for 24 weeks (6 hours per week)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Neurorehabilitation therapy
Number of subjects: 38
Study: 27149033

Group type: EXPERIMENTAL
Intervention: Catheter ablation with continuation of baseline antiarrhythmic medications
Number of subjects: 259

Group type: COMPARATOR
Intervention: Escalated antiarrhythmic drug therapy (including amiodarone and mexiletine)
Number of subjects: 259
Study: 24119840

Group type: EXPERIMENTAL
Intervention: Daily topical exit-site application of antibacterial honey plus standard exit-site care
Number of subjects: 371

Group type: COMPARATOR
Intervention: Standard exit-site care plus intranasal mupirocin prophylaxis (control group)
Number of subjects: 371
Study: 22539169

Group type: EXPERIMENTAL
Intervention: Partial sleep deprivation (<5 h)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control sleep (>7 h)
Number of subjects: 13
Study: 21427992

Group type: EXPERIMENTAL
Intervention: safocid (1 g of seknidasol, 1 g of azitromycin, 150 mg of fluconasol)
Number of subjects: 128
Study: 18630538

Group type: EXPERIMENTAL
Intervention: fu-needle
Number of subjects: 60

Group type: COMPARATOR
Intervention: routine acupuncture
Number of subjects: 60
Study: 16496206

Group type: EXPERIMENTAL
Intervention: Comprehensive psychosocial interventions for autism
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Innovative treatment designs
Number of subjects: 0
Study: 11805482

Group type: EXPERIMENTAL
Intervention: Tc-99m tetrofosmin myocardial SPECT exercise and resting imaging; dosage: 370 MBq (10 mCi) during exercise, 740 MBq (20 mCi) at rest; duration: imaging performed at specified intervals after injection
Number of subjects: 75

Group type: COMPARATOR
Intervention: Tc-99m tetrofosmin myocardial SPECT exercise and resting imaging
Number of subjects: 75
Study: 10524882

Group type: EXPERIMENTAL
Intervention: No scalpel approach
Number of subjects: 1429

Group type: COMPARATOR
Intervention: Standard incision approach
Number of subjects: 1429
Study: 8528716

Group type: EXPERIMENTAL
Intervention: Work site smoking restrictions
Number of subjects: 20801

Group type: EXPERIMENTAL
Intervention: Exposure to ETS
Number of subjects: 20801

Group type: EXPERIMENTAL
Intervention: Bothered by smokiness
Number of subjects: 20801

Group type: EXPERIMENTAL
Intervention: Unsafe working environment
Number of subjects: 20801
Study: 1657803

Group type: EXPERIMENTAL
Intervention: Itraconazole with isoconazole cream
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Itraconazole with keratolytic cream
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Itraconazole with placebo cream
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Griseofulvin with isoconazole cream
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Griseofulvin with keratolytic cream
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Griseofulvin with placebo cream
Number of subjects: 90
Study: 6176320

Group type: EXPERIMENTAL
Intervention: Combined modality therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Local nodal radiotherapy followed by chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus radiotherapy to areas of bulky disease
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Doxorubicin-containing regimen
Number of subjects: 0
Study: 30954710

Group type: EXPERIMENTAL
Intervention: Real-time fMRI neurofeedback training (NFT) with feedback on auditory cortex activity
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham feedback (control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Real-time fMRI neurofeedback training (NFT)
Number of subjects: 0
Study: 28821320

Group type: EXPERIMENTAL
Intervention: Exercise (EX) - 45 minutes at 65% of maximal capacities
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control (CON) - remained seated
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Exercise (EX)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 28
Study: 25618890

Group type: EXPERIMENTAL
Intervention: Cognitive functional approach for 8 weeks
Number of subjects: 36

Group type: COMPARATOR
Intervention: Usual care from coaches
Number of subjects: 36
Study: 23657122

Group type: EXPERIMENTAL
Intervention: Combined vibration and wobble board training
Number of subjects: 33
Study: 21285133

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Exemestane
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Anastrozole
Number of subjects: 154
Study: 19720808

Group type: EXPERIMENTAL
Intervention: Fixed FEV(1)/FVC ratio of 0.70
Number of subjects: 815

Group type: EXPERIMENTAL
Intervention: Fixed FEV(1)/FVC ratio of 0.75
Number of subjects: 815

Group type: EXPERIMENTAL
Intervention: Fixed FEV(1)/FVC ratio of 0.80
Number of subjects: 815
Study: 17927859

Group type: EXPERIMENTAL
Intervention: Video-assisted thoracoscopic surgery (VATS)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Minimal incision thoracotomy (MIT)
Number of subjects: 47
Study: 15380290

Group type: EXPERIMENTAL
Intervention: LAAM
Number of subjects: 16

Group type: COMPARATOR
Intervention: Methadone
Number of subjects: 16

Group type: COMPARATOR
Intervention: (R)-methadone
Number of subjects: 16
Study: 11594259

Group type: EXPERIMENTAL
Intervention: Formoterol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Salmeterol
Number of subjects: 0
Study: 9576424

Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7881703

Group type: EXPERIMENTAL
Intervention: 100 mg methylprednisolone tablet (Medrol)
Number of subjects: 14

Group type: COMPARATOR
Intervention: 100 mg methylprednisolone intravenous formulation (Solu‐Medrol)
Number of subjects: 14
Study: 2850132

Group type: EXPERIMENTAL
Intervention: Enalapril (10 mg IV)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Enalapril (30 mg day‐1 for 3 months)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 30383486

Group type: EXPERIMENTAL
Intervention: Cholecalciferol (D3) 2,000 IU daily
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Cholecalciferol (D3) 3,000 IU daily
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ergocalciferol (D2) 50,000 IU weekly
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ergocalciferol (D2) 50,000 IU twice weekly
Number of subjects: 100
Study: 27806644

Group type: EXPERIMENTAL
Intervention: F(ab')2 with maintenance
Number of subjects: 122

Group type: COMPARATOR
Intervention: F(ab')2 with placebo maintenance
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Fab with maintenance
Number of subjects: 122
Study: 25296727

Group type: EXPERIMENTAL
Intervention: Worksite physical activity intervention (AME for Activity)
Number of subjects: 1260
Study: 24263123

Group type: COMPARATOR
Intervention: L‐NMMA in healthy control subjects (CON)
Number of subjects: 22

Group type: COMPARATOR
Intervention: L‐NMMA in patients with CHF
Number of subjects: 22
Study: 21771174

Group type: EXPERIMENTAL
Intervention: The perioperative dialogue (PD)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Standard perioperative care (control group)
Number of subjects: 93
Study: 18997085

Group type: EXPERIMENTAL
Intervention: Patients with MacTel type 2
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control subjects (age-matched normal subjects)
Number of subjects: 26
Study: 16426096

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 4417

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 4417

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4417
Study: 14991636

Group type: EXPERIMENTAL
Intervention: Cyclosporin
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 40
Study: 11506841

Group type: EXPERIMENTAL
Intervention: Fiberoptic catheter
Number of subjects: 90

Group type: COMPARATOR
Intervention: Microtransducer catheter
Number of subjects: 90
Study: 9209198

Group type: EXPERIMENTAL
Intervention: Estrogen plus progesterone plus calcium
Number of subjects: 236

Group type: COMPARATOR
Intervention: Calcium alone
Number of subjects: 236
Study: 8427434

Group type: EXPERIMENTAL
Intervention: Dexamethasone (10 mg single-dose IM injection)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo (saline IM injection)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 2831320

Group type: EXPERIMENTAL
Intervention: Linoleic acid (4 g daily safflower seed oil)
Number of subjects: 13
Study: 30514795

Group type: EXPERIMENTAL
Intervention: Individualized Survivorship Care Plans (SCPs)
Number of subjects: 495

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 495
Study: 28744821

Group type: EXPERIMENTAL
Intervention: Distributed instruction
Number of subjects: 80

Group type: COMPARATOR
Intervention: Massed instruction
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Blocked practice
Number of subjects: 80

Group type: COMPARATOR
Intervention: Mixed practice
Number of subjects: 80
Study: 26766754

Group type: EXPERIMENTAL
Intervention: Recovery Speaks intervention (one-hour performance followed by discussion)
Number of subjects: 27

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 27
Study: 23899828

Group type: EXPERIMENTAL
Intervention: Exercise training (aerobic exercise three times per week for 12 weeks)
Number of subjects: 248

Group type: COMPARATOR
Intervention: Usual activity (control group)
Number of subjects: 248
Study: 22879677

Group type: EXPERIMENTAL
Intervention: Deltoid, triceps, or both twitches (Group DT)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Biceps twitches (Group B)
Number of subjects: 300
Study: 19548448

Group type: EXPERIMENTAL
Intervention: Intensive acupoints thread embedding (IATE) at Dachangshu (BL 25), Tianshu (ST 25), Zhongji (CV 3), and Zusanli (ST 36) for STC patients (62 patients)
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Intensive acupoints thread embedding (IATE) at the same acupoints and local anal operation for MC patients (62 patients)
Number of subjects: 310

Group type: COMPARATOR
Intervention: Oral administration of Simo Decoction for STC patients in control group I (62 patients)
Number of subjects: 310

Group type: COMPARATOR
Intervention: Oral administration of Simo Decoction for MC patients in control group II (62 patients)
Number of subjects: 310

Group type: COMPARATOR
Intervention: Local anal operation alone for MC patients in control group III (62 patients)
Number of subjects: 310
Study: 17884516

Group type: EXPERIMENTAL
Intervention: 2 sterile surgical gloves
Number of subjects: 42

Group type: COMPARATOR
Intervention: nonsterile disposable inner glove under a sterile surgical glove
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 42
Study: 15127082

Group type: EXPERIMENTAL
Intervention: citalopram (20 mg)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: escitalopram (10 mg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 15
Study: 12173168

Group type: EXPERIMENTAL
Intervention: Foster Pain Intervention (FPI)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Routine information through videotaped instruction (Control)
Number of subjects: 70
Study: 10093686

Group type: EXPERIMENTAL
Intervention: Granulocyte macrophage colony stimulating factor (GM-CSF)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117
Study: 7587035

Group type: EXPERIMENTAL
Intervention: Cefotaxime 2 g every 12 h
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ceftriaxone 4 g once daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ceftriaxone 2 g every 12 h
Number of subjects: 0
Study: 2378239

Group type: EXPERIMENTAL
Intervention: alfentanil + 67% N2O + 33% O2
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: alfentanil + 67% N2O + 33% O2 + droperidol 0.015 mg/kg
Number of subjects: 74

Group type: COMPARATOR
Intervention: alfentanil + 100% O2 + 0.7% isoflurane
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Group I (alfentanil + 67% N2O + 33% O2)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Group II (alfentanil + 67% N2O + 33% O2 + droperidol 0.015 mg/kg)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Group III (alfentanil + 100% O2 + 0.7% isoflurane)
Number of subjects: 74
Study: 489767

Group type: EXPERIMENTAL
Intervention: 100 mg indoprofen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 200 mg indoprofen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 600 mg aspirin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30845817

Group type: EXPERIMENTAL
Intervention: Cariprazine 1.5 mg/day
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Cariprazine 3.0 mg/day
Number of subjects: 480

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 480
Study: 27807948

Group type: EXPERIMENTAL
Intervention: Bioresorbable everolimus‐eluting scaffolds (BVS)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Pt‐Cr everolimus‐eluting stent with abluminal bioabsorbable polymer (Synergy)
Number of subjects: 200
Study: 26241349

Group type: EXPERIMENTAL
Intervention: 16 kilocalories per kilogram of body weight per week (KKW) for 12 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 4 KKW for 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 23657862

Group type: EXPERIMENTAL
Intervention: Lightweight mesh (LWM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Heavyweight mesh (HWM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study: 22879808

Group type: EXPERIMENTAL
Intervention: Formal workshop in EBM literature searching skills
Number of subjects: 121
Study: 19090446

Group type: EXPERIMENTAL
Intervention: Low threshold intervention consisting of an age-adapted nutrition and exercise program
Number of subjects: 365

Group type: COMPARATOR
Intervention: Low threshold intervention (non-participants)
Number of subjects: 365

Group type: COMPARATOR
Intervention: Control group (not informed children)
Number of subjects: 365
Study: 17288692

Group type: EXPERIMENTAL
Intervention: Atomoxetine
Number of subjects: 201

Group type: COMPARATOR
Intervention: Standard Current Therapy (SCT)
Number of subjects: 201
Study: 15450616

Group type: EXPERIMENTAL
Intervention: Quick-change method
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Double infusion method
Number of subjects: 30
Study: 11868687

Group type: EXPERIMENTAL
Intervention: Nurse-led weaning from mechanical ventilation
Number of subjects: 3

Group type: COMPARATOR
Intervention: Doctor-led care (Control)
Number of subjects: 3
Study: 9492772

Group type: EXPERIMENTAL
Intervention: Ritonavir 600 mg twice daily (n = 543)
Number of subjects: 1090

Group type: COMPARATOR
Intervention: Placebo (n = 547)
Number of subjects: 1090
Study: 8288782

Group type: EXPERIMENTAL
Intervention: Acitretin (20 to 30 mg/day for 16 weeks)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study: 2205115

Group type: EXPERIMENTAL
Intervention: doxepin hydrochloride, up to 150 mg/day
Number of subjects: 15

Group type: COMPARATOR
Intervention: inert medication
Number of subjects: 15
Study: 198914

Group type: EXPERIMENTAL
Intervention: Stage grouping modification suggested by the Radiation Therapy Oncology Group
Number of subjects: 403

Group type: COMPARATOR
Intervention: Joint Committee classification
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: Resection of small peripheral lesions without metastatic lymph node involvement
Number of subjects: 403
Study: 30666827

Group type: EXPERIMENTAL
Intervention: Enalapril 5 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Candesartan 8 mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 18
Study: 29082858

Group type: EXPERIMENTAL
Intervention: Guided ACTonPain
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Unguided ACTonPain
Number of subjects: 302

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 302
Study: 24815199

Group type: EXPERIMENTAL
Intervention: Methylnaltrexone 0.15 mg/kg
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: Methylnaltrexone 0.30 mg/kg
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: Methylnaltrexone 0.30 mg/kg with ≥ 150 mg/day baseline morphine equivalent doses
Number of subjects: 288

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: Pooled Methylnaltrexone
Number of subjects: 288
Study: 23098281

Group type: EXPERIMENTAL
Intervention: Intensity-modulated radiotherapy (IMRT)
Number of subjects: 184

Group type: COMPARATOR
Intervention: 3-dimensional conformal radiotherapy (3DCRT)
Number of subjects: 184
Study: 21596189

Group type: EXPERIMENTAL
Intervention: Postoperative patient‐controlled epidural analgesia (PCEA) with continuous infusion of ropivacaine and fentanyl (Group I)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Postoperative patient‐controlled continuous wound catheter infusion of ropivacaine (Group II)
Number of subjects: 38
Study: 19884547

Group type: EXPERIMENTAL
Intervention: Mammography screening intervention
Number of subjects: 8
Study: 18823218

Group type: EXPERIMENTAL
Intervention: Posaconazole oral suspension 200 mg 3 times/day with meals or a nutritional supplement for a minimum of 7 days to achieve steady state and for a maximum of 12 weeks.
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Posaconazole oral suspension 200 mg 3 times/day
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Posaconazole
Number of subjects: 194

Group type: COMPARATOR
Intervention: Standard azoles (fluconazole and itraconazole)
Number of subjects: 194
Study: 15114082

Group type: EXPERIMENTAL
Intervention: Celsior solution
Number of subjects: 105

Group type: COMPARATOR
Intervention: University of Wisconsin (UW) solution
Number of subjects: 105
Study: 11179517

Group type: EXPERIMENTAL
Intervention: tirofiban plus heparin
Number of subjects: 834

Group type: COMPARATOR
Intervention: heparin alone
Number of subjects: 834
Study: 9484194

Group type: EXPERIMENTAL
Intervention: Fourth-year student preceptors
Number of subjects: 93

Group type: COMPARATOR
Intervention: Faculty preceptors
Number of subjects: 93
Study: 8275477

Group type: EXPERIMENTAL
Intervention: ICI 182780 (6 mg)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control (no preoperative treatment)
Number of subjects: 56
Study: 3178925

Group type: EXPERIMENTAL
Intervention: 1000 mg acetylsalicylic acid (ASA)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 1000 mg paracetamol
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31708998

Group type: COMPARATOR
Intervention: 2-phase pattern
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Infant-derived pattern
Number of subjects: 10
Study: 29340354

Group type: EXPERIMENTAL
Intervention: Four immediately loaded mini dental implants (MDIs)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Two standard‐sized interconnected implants (STL)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Four MDIs
Number of subjects: 50

Group type: COMPARATOR
Intervention: Two STL implants
Number of subjects: 50
Study: 26630974

Group type: EXPERIMENTAL
Intervention: Vitamin K1 ≥ 0.76 and 25(OH)D ≥ 50 nmol/l
Number of subjects: 21774

Group type: EXPERIMENTAL
Intervention: Vitamin K1 ≥ 0.76 and 25(OH)D < 50 nmol/l
Number of subjects: 21774

Group type: EXPERIMENTAL
Intervention: Vitamin K1 < 0.76 and 25(OH)D ≥ 50 nmol/l
Number of subjects: 21774

Group type: EXPERIMENTAL
Intervention: Vitamin K1 < 0.76 and 25(OH)D < 50 nmol/l
Number of subjects: 21774
Study: 24131095

Group type: EXPERIMENTAL
Intervention: Intradermal radiofrequency (RF) prior to hyaluronic acid (HA) filler
Number of subjects: 10

Group type: COMPARATOR
Intervention: Hyaluronic acid (HA) filler alone
Number of subjects: 10
Study: 22814178

Group type: EXPERIMENTAL
Intervention: Valsartan 320 mg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Non-RAAS regimen
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Valsartan
Number of subjects: 80

Group type: COMPARATOR
Intervention: Non-RAAS
Number of subjects: 80
Study: 20659545

Group type: EXPERIMENTAL
Intervention: GBQDYS decoction
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 68
Study: 17980273

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy (CEA) with shunting, patching, and intraoperative completion duplex ultrasound imaging
Number of subjects: 391
Study: 15736522

Group type: EXPERIMENTAL
Intervention: Standard Gamble (SG)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Visual Analogue Scale (VAS)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Convergent validity assessment
Number of subjects: 50
Study: 11835456

Group type: EXPERIMENTAL
Intervention: Intramuscular botulinum toxin type A (BT‐A) with electrical stimulation (Group A, n = 6)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Intramuscular botulinum toxin type A (BT‐A) alone (Group B, n = 6)
Number of subjects: 12
Study: 9653480

Group type: EXPERIMENTAL
Intervention: Diode laser
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Nd:YAG laser
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: CO2 laser
Number of subjects: 46
Study: 8137977

Group type: EXPERIMENTAL
Intervention: Coculture on Vero cells
Number of subjects: 16

Group type: COMPARATOR
Intervention: Routine embryo culture medium
Number of subjects: 16